The Official Launch of the Labcorp Singapore Bioanalytical Services and Central Laboratory, is a reaffirmation of our commitment to continue our efforts in providing bioanalytical solutions to all our clients across the fast-growing APAC region by driving strategic partnerships, quality and operational excellence.
In this video, learn about the central pharmacy management and in-human infusion services to reduce travel and investigator site staff burden of the trial.
The development pathway for engineered cell-based therapies faces several unique challenges, particularly with safety assessment and medical monitoring.
Watch our subtitled on-demand webinar to hear the presenters discuss aspects of an adoptive cell therapy preclinical program that are central to an IND/IMPD submission - namely, in vitro and in vivo pharmacology, toxicology and pharmacokinetics (PK) assessments using the appropriate models & test systems.
The COVID-19 pandemic has impacted many facets of life? including pharmacovigilance (PV). The "New Normal" has required us to quickly adapt standard processes and develop new approaches to address unique safety needs.
Accelerate your molecule's success with a programmatic approach to drug development that advances your molecule swiftly through critical milestones while maximizing the value of your asset.
